These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
55 related items for PubMed ID: 1455411
1. DDAVP infusion does not affect plasma levels of endothelin-1 in four normal subjects. Marasini B, Cugno M, Bassani C, Fabrizi I, Bottasso B, Agostoni A. Thromb Haemost; 1992 Nov 10; 68(5):621. PubMed ID: 1455411 [No Abstract] [Full Text] [Related]
7. Local and systemic effects of intra-arterial desmopressin in healthy volunteers and patients with type 3 von Willebrand disease. Role of interleukin-6. Newby DE, Stewart A, Witherow FN, Grieve S, Dawson P, Fox KA, Webb DJ, Ludlam CA. Thromb Haemost; 2000 Aug 10; 84(2):195-203. PubMed ID: 10959689 [Abstract] [Full Text] [Related]
10. The effect of desamino-D-arginine vasopressin (DDAVP) and naloxone infusions on factor VIII and possible endothelial cell (EC) related activities. Moffat EH, Giddings JC, Bloom AL. Br J Haematol; 1984 Aug 10; 57(4):651-62. PubMed ID: 6430337 [Abstract] [Full Text] [Related]
11. Intranasal and intravenous administration of desmopressin: effect on F VIII/vWF, pharmacokinetics and reproducibility. Lethagen S, Harris AS, Sjörin E, Nilsson IM. Thromb Haemost; 1987 Dec 18; 58(4):1033-6. PubMed ID: 3127915 [Abstract] [Full Text] [Related]
12. Unchanged plasma concentrations of endothelin-1 in healthy men during short-term infusions of AMP, dDAVP and of norepinephrine. Wagner OF, Nowotny P, Vierhapper H. Horm Metab Res; 1991 Apr 18; 23(4):191-2. PubMed ID: 1831436 [No Abstract] [Full Text] [Related]
13. Impaired fibrinolytic response to DDAVP in patients with von Willebrand's disease. Sultan Y, Loyer F, Venot A. Nouv Rev Fr Hematol (1978); 1992 Apr 18; 34(1):55-60. PubMed ID: 1523100 [Abstract] [Full Text] [Related]
14. Additive effect of dDAVP and standard heparin in increasing plasma t-PA. Agnelli G, Levi M, Cosmi B, ten Cate JW, Nenci GG. Thromb Haemost; 1989 Jun 30; 61(3):507-10. PubMed ID: 2508260 [Abstract] [Full Text] [Related]
15. Study of endothelial t-PA and vWf in normal subjects and in von Willebrand's disease. Wieczorek I, Ludlam CA, MacGregor IR. Blood Coagul Fibrinolysis; 1994 Jun 30; 5(3):329-34. PubMed ID: 8075304 [Abstract] [Full Text] [Related]
16. Normal response to DDAVP in patients with plathology of the hypothalamoneurohypophyseal axis. Vincente V, Corrales J, Miralles J, Alberca I. Thromb Res; 1987 Mar 01; 45(5):695-7. PubMed ID: 3109066 [No Abstract] [Full Text] [Related]
17. Shortening of bleeding time by 1-deamino-8-arginine vasopressin (DDAVP) in the absence of platelet von Willebrand factor in Gray platelet syndrome. Pfueller SL, Howard MA, White JG, Menon C, Berry EW. Thromb Haemost; 1987 Dec 18; 58(4):1060-3. PubMed ID: 3502198 [Abstract] [Full Text] [Related]
20. The effect of 6% hydroxyethyl starch and desmopressin infusion on von Willebrand factor: ristocetin cofactor activity. Lazarchick J, Conroy JM. Ann Clin Lab Sci; 1995 Dec 18; 25(4):306-9. PubMed ID: 7545380 [Abstract] [Full Text] [Related] Page: [Next] [New Search]